Update on gene editing for sickle cell disease and beta-thalassemia

Clinical Impact

Dec 5

Written By Frances Benson

2020

Frances Benson

Cell therapy demonstrates durable responses in multiple myeloma

Morphic Therapeutic appoints Dr. Martin W. Edwards as Board Director